H19 in Serum Extracellular Vesicles Reflects Resistance to AR Axis-targeted Therapy Among CRPC Patients.

Taku KatoKyojiro KawakamiKosuke MizutaniTatsuya AndoYasuhiro SakaiKouhei SakuraiShohei ToyotaHidetoshi EharaHiroyasu ItoMasafumi Ito

Published in: Cancer genomics & proteomics (2023)

EV-H19 may negatively correlate with AR-signaling activity and could be a marker to diagnose ARAT-resistance among CRPC patients.

Keyphrases